Are muscular dystrophies always inherited, unlike some myopathies? 

Muscular dystrophies and myopathies are both medical classifications for conditions that cause primary muscle weakness, but they differ significantly in their origins and how they appear within a family. While the two terms are sometimes used interchangeably by the public, muscular dystrophy is a specific type of genetic disorder, whereas myopathy is a much broader category that includes conditions caused by external factors. Understanding whether a muscle condition is something a person is born with or something they have developed later in life is a fundamental part of the diagnostic journey in the UK. 

What We’ll Discuss in This Article 

• The clinical definition of muscular dystrophy as a genetic condition. 

• How spontaneous genetic mutations can occur without a family history. 

• The difference between inherited muscle diseases and acquired myopathies. 

• Common causes of acquired muscle weakness, such as inflammation and medication. 

• Why certain myopathies are considered reversible while dystrophies are not. 

• The role of UK specialists in identifying the cause of muscle dysfunction. 

Muscular dystrophies are always considered genetic conditions because they are caused by mutations in the genes responsible for the structure and function of muscle fibres. This means that the blueprint for the disease is present in the person’s DNA from the moment of conception, even if symptoms do not appear until much later in life. Muscular dystrophy is a group of inherited genetic conditions that gradually cause the muscles to weaken, leading to an increasing level of disability. In these cases, the body is unable to produce the proteins needed to protect and repair muscle cells, which leads to the progressive wasting characteristic of the disease. 

Spontaneous Mutations and the Absence of Family History 

One of the most common misconceptions is that a condition must be seen in a parent or grandparent to be considered inherited or genetic. In the context of muscular dystrophy, a person can be the first in their family to have the condition due to what is known as a spontaneous or de novo mutation. This occurs when a genetic fault happens by chance during the development of the egg or sperm, or very early in the development of the embryo. 

Even though there may be no prior family history, the condition is still genetic because the fault is now part of that individual’s DNA. Once this mutation has occurred, that person may then be able to pass the condition on to their own children, depending on the specific inheritance pattern of the dystrophy. This highlights that while muscular dystrophies are always genetic, they are not always inherited from a parent who also has the condition. 

The Broad Spectrum of Myopathies 

The term myopathy is an umbrella term that simply means a disease of the muscle tissue. While it includes all muscular dystrophies, it also encompasses a wide variety of other conditions that are not related to genetics. Unlike muscular dystrophies, which are defined by a progressive breakdown of muscle structure, many myopathies involve a functional problem where the muscles are structurally intact but are being prevented from working correctly by another factor. 

Myopathies are generally split into two groups: inherited and acquired. Inherited myopathies, such as congenital myopathies or metabolic muscle diseases, are similar to dystrophies in that they are caused by genetic faults. However, acquired myopathies are entirely different because they develop during a person’s life due to an illness, an injury, or an environmental trigger. These acquired types are not part of the person’s genetic makeup and cannot be passed on to their children. 

Comparing Inherited and Acquired Muscle Disorders 

Distinguishing between a genetic dystrophy and an acquired myopathy is one of the most important tasks for a neurologist or muscle specialist. The cause of the weakness determines everything from the likely progression of the disease to the treatment options available. 

Feature	Muscular Dystrophies	Inherited Myopathies	Acquired Myopathies
Primary Cause	Genetic mutation	Genetic mutation	External triggers/Illness
Genetic Nature	Always genetic	Always genetic	Not genetic
Inherited from Parents	Often, but not always	Often, but not always	Never
Can it be Reversible	No	No	Yes, in many cases
Disease Progression	Typically progressive	Often stable or slow	Depends on the trigger

Some myopathies are caused by the immune system attacking healthy muscle tissue, which results in inflammation, pain, and weakness. These acquired inflammatory conditions, such as polymyositis or dermatomyositis, are not inherited. Because they are caused by an overactive immune response rather than a genetic fault, they can often be managed or improved with medications that suppress the immune system. 

Triggers for Non-Inherited Muscle Weakness 

Acquired myopathies can be triggered by a vast range of factors that have nothing to do with a person’s ancestry. One common example is endocrine myopathy, which occurs when a hormonal imbalance, such as an underactive or overactive thyroid, interferes with muscle metabolism. In these instances, once the underlying thyroid problem is treated with medication, the muscle weakness often resolves completely. 

Another significant category is toxic myopathy, where external substances cause damage to the muscle fibres. This can include certain prescribed medications, such as statins used to lower cholesterol, or the long-term excessive use of alcohol. Because these conditions are acquired, they are not progressive in the same way that a dystrophy is. If the toxin or medication is removed early enough, the muscles can often recover their strength and function. 

The Importance of Accurate Diagnosis in the UK 

In the UK, the process of determining whether a muscle condition is inherited or acquired involves highly specialised testing. This usually starts with a detailed family history and a clinical examination to see which muscles are affected. Genetic testing is now a standard part of the process for anyone suspected of having a muscular dystrophy, as identifying the specific mutation can confirm the diagnosis without the need for more invasive procedures. 

In cases where the cause is unclear, a muscle biopsy may be performed. This involves taking a tiny sample of muscle tissue to look at the cells under a microscope. This can show whether the muscle fibres are being destroyed by a genetic fault or if they are surrounded by inflammatory cells, which would point to an acquired autoimmune condition. Differentiating between these causes is vital because it allows the healthcare team to provide the most appropriate support and, in the case of acquired myopathies, potentially offer treatments that can reverse the weakness. 

Conclusion 

Muscular dystrophies are always genetic in nature, regardless of whether they were passed down through generations or resulted from a spontaneous mutation. In contrast, myopathies are a diverse group of disorders that include many acquired types caused by inflammation, toxins, or other health conditions. While genetic muscle diseases are currently managed as long-term conditions, many acquired myopathies can be successfully treated or even cured by addressing the underlying trigger. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This guide was written by the Medical Content Team and reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine, surgery, and emergency care. The content adheres to clinical standards set by the NHS and NICE for the education of the public on neuromuscular conditions. It is intended to provide general information and does not replace the need for a professional medical consultation or a formal diagnosis.